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We investigated the capacity of three sunscreen compounds 
to protect mice from the inflammatory and immunosuppres-
sive effects of ultraviolet radiation (UVR). The sunscreen 
preparations contained 7.5% 2-ethylhexyl-p-methoxycinna-
mate, 8% octyl-N-dimethyl-p-aminobenzoate, or 6% ben-
zophenone-3 in an oil-in-water emulsion. Skin swelling was 
used as the measure of their effect on UVR-induced inflam-
mation, and immunosuppression was assessed by contact sen-
sitization with 2,4-dinitrofluorobenzene applied to UV -irra-
diated skin (local suppression) or a distant site (systemic 
suppression). The sunscreens were applied to the shaved dor-
sal skin of C3H mice, which were then given a single dose of 
UVR ranging from 2 to 32 kJ/m2 within the UVB (280-
320 nm) region. All three sunscreens gave complete protec-
E xposure of humans [1,2] and rodents [3 -7] to ultraviolet radiation (UVR) decreases their contact hyper~e~sitivity (CHS) response to haptens. The ImmunologIC Impair-ment caused by UVR can be divided into local and sys-temic effects [3]. Local immunosuppression is defined as 
the diminished CHS response observed when haptens are applied 
through UV-irradiated skin. Exposure to UVR can also result in a 
diminished CHS response when haptens are applied at a distant, 
non - UV -irradiated site; this is referred to as systemic immunosup-
pression. In experimental animals, the UVR-induced unresponsive-
ness to haptens is associated with the presence of hapten-specific 
T -suppressor cells [7 - 9]. The mechanisms by which UVR activates 
the suppressor rather than the effector arm of the immune response 
are not completely understood; however, an alteration in the activ-
ity of epidermal Langerhans cells has been implicated in local immu-
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tion against local suppression of contact hypersensitivity 
caused by a dose of2 kJ/m2 UVB. They also protected against 
both inflammation and systemic immunosuppression caused 
by UVR; however, protection was highly dependent on the 
UVR dose. Furthermore, the sunscreens were less effective in 
protecting against systemic immunosuppression than against 
inflammation. These results indicate that immunosuppres-
sion is less sensitive to the protective effects of the sunscreens 
than inflammation and that protection against UVR-induced 
inflammation does not necessarily imply prevention of im-
munologic alterations. In addition, these studies suggest that 
UVR-induced immunosuppression and inflammation may 
involve different mechanisms. ] Invest Dermatol 100:254-
259, 1993 
nosuppression [5,10,11]. The production of soluble factors may be 
involved in both local [11-13] and systemic immunosuppression 
[6,14 - 16]. Recently, strong evidence was presented indicating that 
on the molecular level, DNA damage in the form of pyrimidine 
dimers is the initiating event for local [17] and systemic [17,18] 
immunosuppressive effects of UVR. 
UVR-induced immunosuppression plays a crucial role in the de-
velopment of skin cancers in mice. Exposure of mice to UVR sup-
presses their ability to reject highly antigenic, UVR-induced tumors 
l19 ,20]. The mechanisms responsible for this immunosuppressive 
effect are similar to those involved in suppression of CHS [7 - 9] . 
UVR is the major carcinogenic agent in the etiology of human skin 
cancers, at least for basal and squamous cell carcinomas [21,22] . 
There is increasing evidence now that UVR may also contribute to 
the development of skin cancers in humans via its effects on the 
immune system [23-25]. 
Sunscreens are highly protective against sunburn in humans [26] 
and protect laboratory animals from chronic UVR-induced skin 
damage [27,28]' carcinogenesis [29], and co-carcinogenesis [30]; 
however, a controversy has arisen whether sunscreens can protect 
against the immunosuppressive effects of UVR. In a number of 
studies, different sunscreens did not protect rodents from a variety of 
UVR-induced effects on the immune system, such as local [31 ,32] 
and systemic [33] suppression of CHS and induction of susceptibil-
ity to tumor transplantation [34]. Moreover, sunscreens lacked the 
capacity to protect against suppression of delayed-type hypersensi-
tivity, natural killer-cell activity, and immunoglobulin production, 
according to Hersey et af [35]. and suppression of mixed lymphocyte 
reaction, according to Van Prag et af [36], by UVR in human sub-
jects. 
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The aim of the present study was to clarify whether three com-
monly used sunscreen compounds, namely, 2-ethylhexyl-p-meth-
oxycinnamate (2-EHMC), octyl-N-dimethyl-p-aminobenzoate (0-
PABA) (both UVB absorbers), and benzophenone-3 (BP-3) 
(UVA + UVB absorber), protect against immunosuppression in-
duced by UVR and to compare immunoprotective capacity with the 
capacity of the sunscreens to protect against UVR-induced inflam-
mation. For this purpose, the photoprotective effects of the differ-
ent sunscreen compounds were studied in a well-characterized 
model of UVR-induced local and systemic suppression of CHS 
using the hapten 2,4-dinitrofluorobenzene (DNFB) and C3H mice. 
The capacity of the sunscreens to protect against system.ic suppres-
sion of CHS was evaluated In UVR dose-response studies across a 
broad range of UVR doses. 
MATERIALS AND METHODS 
Animals Specific-pathogen-free female C3H/HeN(MTV-) 
mice were supplied by the National Cancer Institute-Frederick 
Cancer Research Facility Animal Production Area (Frederick, MD) 
or Charles River Breeding Laboratories (Wilmington, MA). The 
mice were housed in a pathogen-free barrier facility accredited by 
the American Association for Accreditation of Laboratory Animal 
Care, in accordance with current US Department of Agriculture, 
Department of Health and Human Services, and National Institutes 
of Health (NIH) regulations and standards. All animal procedures 
were approved by the Institutional Animal Care and Use Commit-
tee. The mice were given free access to NIH formula 31 mouse food 
and sterilized water. Ambient lighting was controlled to provide a 
regular 12-h light and 12-h dark cycle; 8-16-week-old, age-
matched mice were used in the experiments. 
Sunscreens The sunscreen preparations, kindly provided by 
Estee Lauder Co. (Melville, NY), contained 7.5% 2-EHMC, 8% 
o-PABA (both UVB absorbers) , or 6% BP-3 (UVA + UVB ab-
sorber) in an oil-in-water emulsion. According to the manufactur-
ers, the 2-EHMC- and o-PABA-containing sunscreens blocked 
75% ofUVB (280-320 nm) radiation, the BP-3-containing sun-
screen blocked 45%, and the vehicle blocked 16%, as measured in 
vitro by back-transmittance when the sunscreen preparations were 
applied at 2 mg/ cm2 • Their sun-protection factor (SPF) was rated by 
the manufacturers as approximately 4 - 6 for both UVB sunscreens 
and between 2 and 4 for the BP-3 - containing preparation. 
Determination of Transmission Spectra for Sunscreen Prep-
arations The transmission spectra of the sunscreen preparations 
were measured in our laboratory by spreading the preparations in a 
thin layer over a quartz cuvette and measuring transmission using an 
LKB Biochrom Ultrospec Model 4050 spectrophotometer (LKB 
Biochrom, Cambridge, UK). 
UV Irradiation UVR was provided by a bank of six FS40 sun-
lamps (National Biology Corp., Twinsburg, OH), which have a 
peak emission at 313 nm and deliver 65% of their total energy 
within the UVB (280-320 nm)-wavelength range; their UVB 
irradiance was 5 W /m2 at a 20-cm distance, as determined by an IL 
700 radiometer equipped with an SEE 240 detector fitted with an 
SES280 filter and a quartz diffuser (International Light, Inc., New-
buryport, MA). One day after the dorsal hair of the mice had been 
removed with electric clippers, they were exposed to the radiation 
source while housed five per cage in individual compartments. Be-
cause of shielding by the cage lids, the final irradiance received by 
the animals was approximately 3 W /m2• The sunscreen prepara-
tions were liberally applied (approximately 200 J.Ll/mouse) and 
rubbed on the shaved dorsal surface and tail of the mice 20 min 
before exposure to UVR. 
Measurement of Inflammatory Response The inflammatory 
response was determined by measuring the double skin-fold thick-
ness of the dorsal skin with a spring-loaded micrometer (Mitutoyo, 
Tokyo, Japan) prior to and 24 and 48 h after UVR exposure. Skin 
swelling was determined by subtracting the average skin thickness 
before UV irradiation from that after UV irradiation. Prior to this 
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study we found that the application of the sunscreens or the vehicle 
alone resulted in a small but significant skin swelling. In four exper-
iments (n = 5 in each experimental group), the application of 0-
PABA, 2-EHMC, BP-3, and the vehicle alone gave a mean skin 
swelling (±SEM) (X 10-2 mm) of7.5 ± 0.7, 5.6 ± 1.5,5.4 ± 2.2, 
and 0.1 ± 1.1 at 24 h, and 5.2 ± 1.1, 3.2 ± 1.5, 3.9 ± 1.8, and 
3.4 ± 0.8 at 48 h, respectively. These values were subtracted from 
the skin swelling of sunscreen-treated, UV -irradiated groups to de-
termine net skin swelling. The protection from inflammation by a 
sunscreen was defined as complete protection when there was no 
significant skin swelling in a sunscreen-treated, UV -irradiated 
group 24 and/or 48 h after UVR exposure when compared with 
sunscreen-treated, unirradiated mice; the protection was defined as 
partial protection when there was significant skin swelling, but the 
swelling was significantly different from that of the UV-irradiated 
group without sunscreen. 
Local and Systemic Suppression of CHS Groups of mice, ei-
ther untreated or treated with a sunscreen or the verucle, were 
exposed to the UVR source. During irradiation, the ears of the mice 
were protected from UVR by opaque tape, which was removed after 
exposure. Three days after exposure to UVR, mice were sensitized 
with 50 J.Ll of 0.3% DNFB (Sigma Chemical Co., St. Louis, MO) in 
acetone on shaved, irradiated dorsal skin (assay for local suppression 
of CHS) or on shaved, unirradiated ventral skin (assay for systemic 
suppression of CHS). Five days later, the CHS response was elicited 
by applying 5 J.Ll of 0.2% DNFB in acetone to the ventral and dorsal 
surfaces of both ears. Ear thickness was measured with the microme-
ter before and 24 h after challenge. The percent suppression of CHS 
was determined by the following formula [1 - (A - B)/(C-
B)] X 100, where the letters represent the average ear swelling in 
(A) sensitized and irradiated mice, (B) unsensitized and unirradiated 
mice, and (C) sensitized and unirradiated mice. The percent protec-
tion by a sunscreen was determined by the following formula [1 -
(+ SS/- SS)] X 100, where + SS represents the percent suppression 
of CHS in sunscreen-treated, UV -irradiated mice, and - SS is the 
percent suppression in UV -irradiated mice without sunscreen. The 
protection by a sunscreen from suppression of CHS was defined as 
complete when there was no significant difference in the CHS 
response of the sunscreen-treated and UV -irradiated group from the 
positive control group (sensitized and unirradiated group); the pro-
tection was defined as partial when the CHS response of the sun-
screen-treated, UV -irradiated group was intermediate to the re-
sponses of the sunscreen-untreated, irradiated group and the 
positive control group. 
Statistics The statistical significance of the differences in skin or 
ear swelling among groups was evaluated using the Student two-
tailed t test. Each group contained at least five mice. 
RESULTS 
Sunscreen Transmission Spectra The transmission spectra of 
the two UVB sunscreens, 2-EHMC and o-p ABA, showed very simi-
lar absorption values from 260 to 400 nm and distinct absorption 
peaks near 300 nm (Fig lA). The BP-3 - containing preparation 
absorbed approximately half the amount of UVB radiation as the 
UVB sunscreens; however, its absorption capacity extended across 
the UV A range. Overlap spectra between the emission spectrum of 
the FS40 sunlamp, as measured by an Optronic Model 7 42 spectrora-
diometer (Optronic Laboratories, Inc., Orlando, FL), and the trans-
mission spectra of the sunscreen preparations were calculated by 
multiplication of the relative irradiance values of the FS40 sunlamp 
spectrum by the relative transmission values of the sunscreen prepa-
rations at the different wavelengths (Fig IB). 
Assessment of Minimal Inflammatory Dose Prior to this 
study, we found that measurement of skin swelling was a more 
sensitive indicator of the minimal inflammatory response in C3H 
mice than visual evaluation of erythema, so we used skin swelling as 
our measure. Groups of mice were UV irradi.ated at 40% dose incre-
ments (Fig 2). The minimal inflammatory dose, taken as the ex-
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Figure L (A) UVR transmission spectra. The spectra were determined 
by measuring transmission of the sunscreen preparations using a spectro-
photometer. (B) Overlap between the emission spectrum of the F540 sun-
lamp and the transmission spectra of the sunscreen preparations from A. 
posure required to elicit minimal significant skin swelling, was 
1 kJ/m2. 
Effect of Sunscreens on UVR-Induced Systemic Suppression 
of Contact Sensitization and Inflammation To assess the 
photoprotective capacity of the sunscreen preparations with respect 
to the inflammatory response and systemic suppression of CHS, 
mice were either treated or untreated with a sunscreen or the vehi-
cle; they then were exposed to a UVB dose ranging from 2 to 32 
kJ/m2 (11 - 176 min of exposure). To rule out the possibility that 
the application of a sunscreen or the vehicle per se might influence 
contact sensitization, experiments were initially performed with all 
the necessary control groups. The application of sunscre,en or vehi-
cle alone had no significant effect on the CHS response in unirra-
diated mice or on the background ear-swelling reaction of unsensi-
tized mice (data not shown). 
A typical experiment with the o-PABA-containing sunscreen at 
three different UVR doses is shown in Figure 3. A significant in-
flammatory response, as measured by skin swelling at 24 h, was 
observed in all groups exposed to UVR but not treated with sun-
screen (Fig 3A). The topical application of the O-P ABA - containing 
sunscreen completely protected against skin swelling at 2 and 8 
kJ/m2 and partially protected at 32 kJ/m2. Significant suppression 
of the CHS response was found in all UVR-exposed groups that 
0.36 
'" 
0.5 
~ 0.7 
..., 
~ 
w 
(f) 
0 1.4 
C 
al 2 
> 
::> 2.8 
0 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
f!l 24 h 
rzI 48 h 
20 40 60 80 
- 2 SKIN SWELLING (10 mm) 
100 
Figure 2_ UVR dose - response for induction of inflammation. Groups of 
mice were UV irradiated at 40% dose increments. The minimal inflamma-
tory dose was 1 kJ/m2 UVB radiation, as determined by dorsal skin swell-
ing at 24 and 48 h after UVR exposure; n = 5; data are mean ± 5EM; 
.p < 0.05 versus unirradiated mice. 
were. not treated with sunscreen (Fig 3B). The application of the 
o-P ABA - containing sunscreen completely protected against sup-
pression of the CHS response at 2 kJ/m2 and partially protected at 8 
kJ/m2. No protection was given by the sunscreen at 32 kJ/m2. 
Comparison of the photoprotective capacity for inflammation 
versus immunosuppression at the different UVR doses shows that 
o-P ABA was more protective against the inflammatory response 
than against systemic immunosuppression; similar results were seen 
with 2-EHMC. An experiment with the BP-3-containing sun-
screen is shown in Figure 4. The BP-3 preparation was not as pro-
tective against inflammation as the two UVB sunscreens; however, 
it completely protected against skin swelling at 2 and 4 kJ/m2 and 
partially at 8 kJ/m2 (Fig 4A). The BP-3 preparation completely 
protected against suppression of CHS at 2 kJ/m2 and partially at 4 
and 8 kJ/m2 (Fig 4B). 
A summary of all experiments performed is presented in Table I. 
The protective effects of the sunscreen preparations against inflam-
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Figure 3_ The effect of o-PABA on UVR-induced inflammation and sys-
temic suppression of CH5. Groups of mice were exposed to different 
doses of UVR (kJ/m2), either unprotected or protected by the sunscreen 
(55); n = 5; data are mean ± SEM. (A) Inflammatory response to UVR, as 
measured by dorsal skin swelling 24 h after UVR exposure; .p < 0.005 
and +p < 0.05 versus o-PABA-untreated groups; (B) CHS response to 
DNFB, expressed as ear swelling 24 h after challenge. 5ens, sensitized; 
.p < 0.001 versus positive control group; +p < 0.05 versus positive con-
trol group and o-PABA-untreated, B kJ/m2 UV-irradiated group; values 
ill parwi/'eses represent percent protection by o-PABA from suppression of 
CH5. 
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Figure 4. The effect of BP-3 on UVR-in~uced inflammation a~d sys-
temic suppression of CHS. Groups of ITIlce were exposed to different 
doses of UVR (kJ/m2), either unprotected or protected by the sunscreen 
(SS); n = 5-10; data are mean ± SEM. (A) Inflammatory response to 
UVR, as measured by dorsal skin swelling 48 h after UVR exposure; 
.p < 0.005 and +p < 0.05 versus BP-3-untreated groups; (B) CHS re-
sponse to DNFB, expressed as ear swelling 24 h after challenge; Sens, 
sensitized; .p < 0.001 versus positive control group; +p < 0.01 versus 
positive control group and BP-3 -untreated, UV-irradiated groups; values 
in parentheses represent percent protection by BP-3 from suppression of 
CHS. 
mation and systemic immunosuppression are shown for each sun-
screen preparation at the different UVR doses. The UVB ~unscreens 
containing 2-EHMC or a-PABA completely protected mice agamst 
the inflammatory response up to 8 kJ/m2 UVB, and the BP-3-
containing sunscreen completely protected up to 4 kJ/m2; howe~er, 
the vehicle did not protect at any dose (Table I). Because the mml-
Table I. Protective Effect of Sunscreens Against UVR-
Induced Inflammation and Systemic Immunosuppression 
(kJ/m2) 
UVB 
Treatment" Dose IRb CHS' 
o-PABA (8) 2 +,+ +,-
4 +,+ +,+ 
8 +,+, + +,±,±,-,-
16 ± 
32 ±,± , 
2-EHMC (7) 2 +,+ +,-
4 +,+ +,-
8 +,+,± +,+,±,± 
16 ±,± , 
32 ± 
2 +,+ +,± 
4 +,+ ±,± 
BP-3 (6) 
8 ±,± ±,-,-
16 
Vehicle (4) 2 
4 
8 
16 
• Numbers in parentheses are number of independent experiments performed 
with each treatment agent. 
I Protection from inflammatory response (IR), as measured by skin swelling. 
, Protection from suppression of (CHS). (+) Complete protection, (±) partial pro-
tection, (-) no protection (as defined in Materials alld Methods); each symbol repre-
sents the result of an individual treatment group containing five mice from an 
independent determination. 
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mal inflammatory dose in our mice was 1 kJjm2 (Fig 2), both UVB 
sunscreens gave an anti-inflammatory SPF of at least 8, and the 
BP-3-containing sunscreen gave an SPF of at least 4 in this study. 
We noted considerable variability in the amount of immunoprotec-
tion observed with all sunscreen preparations, particularly at the 
lower doses of UVR; however, the sunscreens gave better protec-
tion at the lower UVR doses than at higher doses in nearly all 
experiments. In certain experiments, both UVB sunscreens com-
pletely protected against systemic suppression of CHS up to 8 kJ/m2 
UVB; the BP-3-containing sunscreen completely protected at 2 
kJjm2 and partially at 4 and 8 kJjm2 UVB (Table I). The minimal 
UVB dose required to elicit systemic suppression of CHS in our 
mice was 2 kJjm2 (data not shown); therefore, the maximal achieva-
ble immunoprotective SPF was 4 for both UVB sunscreens and less 
than 2 for the BP-3 - containing preparation. 
Effect of Sunscreens on UVR-Induced Local Suppression of 
Contact Sensitization After we had evaluated the capacity of 
the sunscreens to protect mice against systemic suppression of CHS, 
we determined their effects on UVR-induced local suppression of 
CHS. To assess the immunoprotective capacity of the sunscreen 
preparations, mice were exposed to 2 kJ/m2 UVB, a dose previously 
found in our laboratory to significantly reduce CHS to haptens 
applied 3 d later to the UV-irradiated site. To test the possibility 
that the topical application of a sunscreen or the vehicle per se might 
interfere with local contact sensitization, groups of unirradiated 
mice were treated with sunscreens or vehicle before sensitization; 
however, the application of neither sunscreen nor vehicle alone 
significantly altered the CHS response. The topical application of 
all sunscreens completely protected against the inflammatory re-
sponse to UVR at this particular dose, whereas the vehicle did not 
protect (Fig SA) significant local suppression of contact sensitiza-
tion was observed in the mice exposed to UVR but not treated with 
a sunscreen (Fig SB) . The 2-EHMC-, a-PABA-, and BP-3 -
containing sunscreens completely protected against UVR-induced 
local suppression of CHS, whereas the vehicle did not (Fig SB). 
DISCUSSION 
In the present study, the sunscreen preparations containing 2-
EHMC or a-PABA (both UVB absorbers) or BP-3 (UVA + UVB 
absorber) protected against UVR-induced systemic and local immu-
nosuppression, as determined by CHS to the contact allergen 
DNFB. The photoprotective capacity of the sunscreens was UVR 
dose dependent with regard to both the skin-swelling response and 
immunosuppression; however, our data also demonstrated that 
their immunoprotective capacity was inferior to their capacity to 
protect against the inflammatory effects ofUVR. The variability we 
noted in the amount of immunoprotection observed with all sun-
screen preparations, particularly at the lower doses ofUVR, might 
have been due to variability in the amount of systemic immunosup-
pression in different experiments; alternatively, it could be due to 
uneven distribution of the sunscreens on the skin. By contrast, there 
was little variability with regard to protection from inflammation. 
This observation further supports the lack of correlation between 
protection from inflammation and immunosuppression. 
The transmission spectra of the sunscreen preparations and their 
overlap spectra with the emission spectrum of the FS40 sunlamp 
implied that the two UVB sunscreens should be equally protective. 
Indeed, we observed approximately equal photoprotective capacity 
of the U VB sunscreens for both inflammatory and immunosuppres-
sive effects of UVR. As expected from its overlap spectrum, the 
BP-3 - containing preparation was less effective in protecting 
against both UVR effects. 
T he results of this study differ somewhat from a number of earlier 
studies in which various sunscreens did not protect against different 
immunosuppressive effects of UVR [31- 36]; however, most 
previous studies [31-36] involved chronic UVR treatment regi-
mens with at least five exposures and higher cumulative UVR doses 
than were applied in our study. Furthermore, UVR dose responses 
were not determined in any of these previous studies. If the total 
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Figure 5. The effect of sunscreens on UVR-induced inflammation and 
local suppression of CHS. Groups of mice were exposed to 2 kJ/m2 of 
UVB, either unprotected or protected by a sunscreen (55); n = 5; data are 
mean ± SEM. (A) Inflammatory response to UVR, as measured by skin 
swelling 48 h after UVR exposure; 'p < 0.05 versus the sunscreen-un-
treated group. (B) CH5 response to DNFB, expressed as ear swelling 24 h 
after challenge; Sens, sensitized; 'p < 0.01 versus positive control group; 
values in parentheses represent percent protection by a sunscreen from 
suppression of CH5. 
UVR dose exceeded the protective capacity of the sunscreens, no 
effect of the sunscreens would be observed, even though they may 
have been protective at lower UVR doses. Thus, the high doses of 
UVR and lack of dose-response information might explain why 
immunoprotection was not noted in any of those studies. 
In a recent study, Reeve et at [37] compared the immunoprotec-
tive effects of o-p ABA - and 2-EHMC - containing sunscreen prepa-
rations in albino hairless mice. The o-PABA-containing prepara-
tion did not protect against systemic immunosuppression, as 
determined by CHS to DNFB, nor did it protect against the estab-
lishment of a tumor-susceptible state, as shown by the growth of 
transplanted UVR-induced tumors. In contrast, the 2-EHMC-
containing preparation protected from both UVR effects; however, 
in their study, o-PABA and 2-EHMC were not suspended in the 
same vehicle, and BP-3 was present in both sunscreen preparations 
but in unequal concentrations. The 2-EHMC preparation contained 
4.5% BP-3, whereas the o-PABA preparation contained only 3% 
BP-3. As demonstrated in our study, BP-3 also exhibited immuno-
protective capacity, and therefore its presence in higher concentra-
tion cou ld have accounted for the superiority of the 2-EHMC-
containing preparation. 
Our finding that sunscreens have immunoprotective capacity is 
in agreement with earlier work by Morison and co-workers, in 
which p-aminobenzoic acid (PABA) gave nearly complete protec-
tion against systemic suppression of CHS in C3H mice and guinea 
pigs after three UVR exposures [38,39]. In addition, Morison and 
Kelley found that PABA protected against UVR-induced tumor 
susceptibility in C3H mice [40] . This latter result differs from that 
of a previous study using C3H mice [34] in which preparations 
containing PABA, PABA esters, and BP-3 had no effect on the 
induction of a tumor-susceptible state by UVR. Differences in meth-
odology (i.e., sunscreen formulations and application, light sources, 
UVR doses, and number of treatments) could account for the dis-
crepancy between those studies [34,40]. It may be important that in 
our and Morison and co-workers' studies, the sunscreens were ap-
plied liberally to the mice, which probably resulted in higher con-
centrations on the skin than the 2 mg or 2 ,u1/cm2 usually used 
[31,33,35 - 37]. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Our results suggest that different mechanisms are involved in 
UVR-induced inflammation and systemic immunosuppression. 
Moreover, they imply that measurement of the skin-swelling re-
sponse to UVR is not an accurate method to determine protection 
from immunologic damage by UVR. The reasons for the lack of 
correlation between protection from inflammation and immunosup-
pression are unknown. It has been suggested that the location of the 
sunscreens in the skin might be important with regard to the immu-
nosuppressive effects ofuVR [33]. Willis and Kligman [41] showed 
that photoprotection by PABA against UVR-induced erythema 
persisted despite repeated stripping of the stratum corneum. There-
fore, Fisher et at [33] concluded that certain sunscreens may "pool" 
beneath the stratum corneum, and, consequently, although sun-
screens may inhibit UVR-induced damage to deeper structures of 
the skin, they might not effectively block the access of UVR to 
urocanic acid, which may serve as an immunomodulator [6] in the 
superficial epidermis. 
Alternatively, the relatively low immunoprotective capacity of 
sunscreens may be due to chemical interactions of sunscreens with 
cellular molecules critical for immunosuppression. In support of 
this theory, increased mutagenesis was found in irradiated bacteria 
in the presence of PABA [42] and cinnamic acid derivatives related 
to 2-EHMC [43]. The investigators concluded that the sunscreens 
inhibited the repair ofUVR-induced DNA damage [42,43] . In ad-
dition, it was reported that PABA can augment the formation of 
pyrimidine dimers in vitro after UV irradiation [44,45]. In another 
study [46], PABA esters alone were capable of inducing DNA dam-
age, and the damage was further augmented after UV irradiation. In 
contrast, we found that sunscreens protected against UVR-induced 
formation of pyrimidine dimers in our mice (unpublished data). 
Thus, a fine balance may exist between photosensitizing and photo-
protective effects of sunscreens [42,46). It was recently demon-
strated that systemic suppression of CHS in UV-irradiated C3H 
mice is, on the molecular level, mainly mediated by DNA damage 
in the form of pyrimidine dimers [17,18] . Therefore, these two 
balancing effects may explain the lack of correlation between the 
protective effects of sunscreens for inflammation and immunosup-
pression: sunscreens might, on the one hand, be capable of inhibit-
ing immunosuppression by prevention of direct UVR-induced dam-
age to DNA and, on the other, contribute to immunosuppression by 
inhibiting repair of pyrimidine dimers or by inducing formation of 
lesions other than pyrimidine dimers. Finally, UVR-induced in-
flammation and immunosuppression may be dependent 011 overlap-
ping but not identical pathways. 
Regardless of the mechanisms involved, our results have im-
portant practical implications. In contrast to previous reports, our 
studies demonstrate that sunscreens do have immunoprotective ca-
pabilities. These capabilities are limited, however, and immunosup-
pression can occur in the absence of measurable skin swelling. This 
means that when subjects expose themselves for prolonged times to 
UVR, although they may be protected from sunburn by sunscreens, 
immunosuppressive effects might still occur. 
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